Chen L - Search Results

1

6-Dithio-2'-deoxyguanosine analogs induce reactive oxygen species-mediated tumor cell apoptosis via bi-targeting thioredoxin 1 and telomerase.

Zhang Y, Zhou J, Ye Q, Zeng K, Pan J, Chen L, Wang Y, Yang B, He Q, Gao J, Zeng S, Yu L. Zhang Y, et al. Among authors: chen l. Toxicol Appl Pharmacol. 2020 Aug 15;401:115079. doi: 10.1016/j.taap.2020.115079. Epub 2020 Jun 1. Toxicol Appl Pharmacol. 2020. PMID: 32497534

2

Studies on the L-2-hydroxy-acid oxidase 2 catalyzed metabolism of S-mandelic acid and its analogues.

Zhang Y, Su C, Lei J, Chen L, Hu H, Zeng S, Yu L. Zhang Y, et al. Among authors: chen l. Drug Metab Pharmacokinet. 2019 Jun;34(3):187-193. doi: 10.1016/j.dmpk.2019.02.003. Epub 2019 Feb 21. Drug Metab Pharmacokinet. 2019. PMID: 30876779

3

A novel human lncRNA SANT1 cis-regulates the expression of SLC47A2 by altering SFPQ/E2F1/HDAC1 binding to the promoter region in renal cell carcinoma.

Gao Z, Chen M, Tian X, Chen L, Chen L, Zheng X, Wang H, Chen J, Zhao A, Yao Q, Zhu Q, Jin S, Hu H, Zeng S, Yu L. Gao Z, et al. Among authors: chen j, chen l, chen m. RNA Biol. 2019 Jul;16(7):940-949. doi: 10.1080/15476286.2019.1602436. Epub 2019 Apr 21. RNA Biol. 2019. PMID: 30951404 Free PMC article.

4

Regulation of OCT2 transcriptional repression by histone acetylation in renal cell carcinoma.

Zhu Q, Yu L, Qin Z, Chen L, Hu H, Zheng X, Zeng S. Zhu Q, et al. Among authors: chen l. Epigenetics. 2019 Aug;14(8):791-803. doi: 10.1080/15592294.2019.1615354. Epub 2019 May 15. Epigenetics. 2019. PMID: 31088315 Free PMC article.

5

Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2.

Chen L, Chen L, Qin Z, Lei J, Ye S, Zeng K, Wang H, Ying M, Gao J, Zeng S, Yu L. Chen L, et al. Acta Pharm Sin B. 2019 Sep;9(5):1008-1020. doi: 10.1016/j.apsb.2019.01.002. Epub 2019 Jan 8. Acta Pharm Sin B. 2019. PMID: 31649850 Free PMC article.

6

Epigenetic Mechanisms Underlying Organic Solute Transporter β Repression in Colorectal Cancer.

Zhou Y, Ye C, Lou Y, Liu J, Ye S, Chen L, Lei J, Guo S, Zeng S, Yu L. Zhou Y, et al. Among authors: chen l. Mol Pharmacol. 2020 Apr;97(4):259-266. doi: 10.1124/mol.119.118216. Epub 2020 Jan 31. Mol Pharmacol. 2020. PMID: 32005758

7

The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma.

Chen L, Wang Z, Xu Q, Liu Y, Chen L, Guo S, Wang H, Zeng K, Liu J, Zeng S, Yu L. Chen L, et al. Theranostics. 2020 Feb 18;10(8):3562-3578. doi: 10.7150/thno.39944. eCollection 2020. Theranostics. 2020. PMID: 32206108 Free PMC article.

8

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents.

Zhou J, Kang Y, Chen L, Wang H, Liu J, Zeng S, Yu L. Zhou J, et al. Among authors: chen l. Front Pharmacol. 2020 Mar 20;11:343. doi: 10.3389/fphar.2020.00343. eCollection 2020. Front Pharmacol. 2020. PMID: 32265714 Free PMC article. Review.

9

Research and development of drug delivery systems based on drug transporter and nano-formulation.

Peng Y, Chen L, Ye S, Kang Y, Liu J, Zeng S, Yu L. Peng Y, et al. Among authors: chen l. Asian J Pharm Sci. 2020 Mar;15(2):220-236. doi: 10.1016/j.ajps.2020.02.004. Epub 2020 Mar 4. Asian J Pharm Sci. 2020. PMID: 32373201 Free PMC article. Review.

10

Metabolic interactions between flumatinib and the CYP3A4 inhibitors erythromycin, cyclosporine, and voriconazole.

Chen J, Guo S, Yu X, Lei J, Xu T, Zhu S, Chen L, Xu P, Zhou X, Yu L. Chen J, et al. Among authors: chen l. Pharmazie. 2020 Sep 1;75(9):424-429. doi: 10.1691/ph.2020.0068. Pharmazie. 2020. PMID: 32797767

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89,019 results

Search Page

Filters